Peter E. Westerweel - Concepedia

Author

Peter E. Westerweel

Also Known As

Hochhaus, Andreas, J Cornelissen, Nicola Montano, P E Westerweel, P. E. WESTERWEEL, P. E. Westerweel, P. Westerweel, P.E. Westerweel, Panayiotis Panayiotidis, Peter E Westerweel

180

Publications

4.3K

Citations

H-Index

Concepts

All Affiliations

Albert Schweitzer Ziekenhuis Erasmus MC University Medical Center Utrecht Radboud University Nijmegen Leiden University Medical Center

About

Peter E. Westerweel is an author at Albert Schweitzer Ziekenhuis specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	12	969
2	Health Sciences	2	2	629
3	Engineering	1	1	118
4	Public Health	1	1	26
5	Biomedical Engineering	1	1	118

Peter E. Westerweel

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial Johan Richter, Joëlle Guilhot, Franz Gruber, The Lancet Oncology Hematological MalignancyMedicineChronic Myeloid LeukaemiaMixed-phenotype Acute LeukemiaHematology	2018	587
Successful Transfer of Umbilical Cord Blood CD34+ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia Patients Harry Dolstra, Mieke W.H. Roeven, Jan Spanholtz, Clinical Cancer Research	2017	203
Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial Stefano Barco, Irene Schmidtmann, Walter Ageno, European Heart Journal	2019	151
The Use of Endothelial Progenitor Cells for Prevascularized Bone Tissue Engineering Jeroen Rouwkema, Peter E. Westerweel, Jan de Boer, Tissue Engineering Part A Progenitor CellsTissue EngineeringEngineeringBiomedical EngineeringInsufficient Blood Supply	2009	118
Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus Peter E. Westerweel, Remco K.M.A.C. Luijten, Imo E. Hoefer, Annals of the Rheumatic Diseases	2007	113
Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial Ingrid M. Bistervels, Andréa Buchmuller, Hanke M.G. Wiegers, The Lancet	2022	93
Progenitor cells and vascular function are impaired in patients with chronic kidney disease Kim E. Jie, Marloes W.T. Bergevoet, Peter E. Westerweel, Nephrology Dialysis Transplantation	2010	86
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism Isabelle Mahé, Marc Carrier, D. Mayeur, New England Journal of Medicine	2025	85
End-stage renal disease causes an imbalance between endothelial and smooth muscle progenitor cells Peter E. Westerweel, Imo E. Hoefer, Peter J. Blankestijn, American Journal of Physiology-Renal Physiology Glomerular DiseaseCell TherapyRenal PathologyImmunologyPathology	2007	83
Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy Peter E. Westerweel, Frank L.J. Visseren, Gideon R. Hajer, European Heart Journal	2008	77

Page 1